Related references
Note: Only part of the references are listed.Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling
Zheng Liu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
The pharmacokinetics and the pharmacodynamics of cannabinoids
Catherine J. Lucas et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Medical Use of Cannabinoids
Ana Isabel Fraguas-Sanchez et al.
DRUGS (2018)
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Elzbieta Wyska et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2016)
Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity
Ricardo Jorge Dinis-Oliveira
DRUG METABOLISM REVIEWS (2016)
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification
Jennifer E. Sager et al.
DRUG METABOLISM AND DISPOSITION (2015)
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
H. M. Jones et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Calibration and validation of a physiologically based model for soman intoxication in the rat, marmoset, guinea pig and pig
Kaizhen Chen et al.
JOURNAL OF APPLIED TOXICOLOGY (2012)
Enhanced Brain Disposition and Effects of Δ9-Tetrahydrocannabinol in P-Glycoprotein and Breast Cancer Resistance Protein Knockout Mice
Adena S. Spiro et al.
PLOS ONE (2012)
Effect of PCBs on the lactational transfer of methyl mercury in mice: PBPK modeling
Sun Ku Lee et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2009)
Therapeutic potential of cannabis in pain medicine
R. D. Hosking et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
A possible role of multidrug resistance-associated protein 2 (Mrp2) in hepatic excretion of PCB126, an environmental contaminant: PBPK/PD modeling
Manupat Lohitnavy et al.
TOXICOLOGICAL SCIENCES (2008)
Validation of Large White Pig as an animal model for the study of cannabinoids metabolism:: Application to the study of THC distribution in tissues
Bertrand Brunet et al.
FORENSIC SCIENCE INTERNATIONAL (2006)
Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana
HJ Zhu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
An updated physiologically based pharmacokinetic model for hexachlorobenzene: Incorporation of pathophysiological states following partial hepatectomy and hexachlorobenzene treatment
YS Lu et al.
TOXICOLOGICAL SCIENCES (2006)
Whole body pharmacokinetic models
I Nestorov
CLINICAL PHARMACOKINETICS (2003)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
Share Paper
